Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × rasburicase × Clear all

NCT00628628 2013-08-01

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Tumor Lysis Syndrome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hyperuricemia